Collegium Pharmaceutical (COLL) Analyst & Key Data

Analyst Consensus

Buy8 analysts

Buy

Updated Sep 12, 2026

Total Analysts8

Buy

8

Hold

3

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score4.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$22.75

Median Target+135.74%

$53.63

Potential upside vs current price

Current Stock Price

$22.75

Median Target+135.74%

$53.63

Potential upside vs current price

Analyst Consensus

Buy8 analysts

Buy

Updated Sep 12, 2026

Total Analysts8

Buy

8

Hold

3

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score4.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$22.75

Median Target+135.74%

$53.63

Potential upside vs current price

Current Stock Price

$22.75

Median Target+135.74%

$53.63

Potential upside vs current price

Collegium Pharmaceutical, Inc.